The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Parkinson's Disease Treatments-Global Market Insights and Sales Trends 2024
Synopsis
Parkinson’s disease is a central nervous system syndrome which affects the motor neuron, mainly characterized by rigidity, tremor, depression, dementia, and so on. Treatment for this disease is mostly symptomatic and almost no curative treatment alternatives are available.
The global Parkinson's Disease Treatments market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Parkinson's Disease Treatments in various end use industries. The expanding demands from the Hospitals, Healthcare Institutes and Others,, are propelling Parkinson's Disease Treatments market. Dopamine Agonists, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Levodopa segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Parkinson's Disease Treatments, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Parkinson's Disease Treatments market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Parkinson's Disease Treatments market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Parkinson's Disease Treatments sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Parkinson's Disease Treatments covered in this report include GSK, Merck, Novartis, Teva, Boehringer Ingelheim, Impax, Abbvie, Bausch Health and Lundbeck, etc.
The global Parkinson's Disease Treatments market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Merck
Novartis
Teva
Boehringer Ingelheim
Impax
Abbvie
Bausch Health
Lundbeck
Sun Pharma
Wockhardt
Acadia
UCB
Global Parkinson's Disease Treatments market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Parkinson's Disease Treatments market, Segment by Type:
Dopamine Agonists
Levodopa
Glutamate Antagonist
Apomorphine
COMT Inhibitors Anticholinergics
MAO-B Inhibitors
Other Drugs
Global Parkinson's Disease Treatments market, by Application
Hospitals
Healthcare Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Parkinson's Disease Treatments companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Parkinson’s disease is a central nervous system syndrome which affects the motor neuron, mainly characterized by rigidity, tremor, depression, dementia, and so on. Treatment for this disease is mostly symptomatic and almost no curative treatment alternatives are available.
The global Parkinson's Disease Treatments market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Parkinson's Disease Treatments in various end use industries. The expanding demands from the Hospitals, Healthcare Institutes and Others,, are propelling Parkinson's Disease Treatments market. Dopamine Agonists, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Levodopa segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Parkinson's Disease Treatments, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Parkinson's Disease Treatments market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Parkinson's Disease Treatments market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Parkinson's Disease Treatments sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Parkinson's Disease Treatments covered in this report include GSK, Merck, Novartis, Teva, Boehringer Ingelheim, Impax, Abbvie, Bausch Health and Lundbeck, etc.
The global Parkinson's Disease Treatments market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Merck
Novartis
Teva
Boehringer Ingelheim
Impax
Abbvie
Bausch Health
Lundbeck
Sun Pharma
Wockhardt
Acadia
UCB
Global Parkinson's Disease Treatments market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Parkinson's Disease Treatments market, Segment by Type:
Dopamine Agonists
Levodopa
Glutamate Antagonist
Apomorphine
COMT Inhibitors Anticholinergics
MAO-B Inhibitors
Other Drugs
Global Parkinson's Disease Treatments market, by Application
Hospitals
Healthcare Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Parkinson's Disease Treatments companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Parkinson's Disease Treatments
1.1 Parkinson's Disease Treatments Market Overview
1.1.1 Parkinson's Disease Treatments Product Scope
1.1.2 Parkinson's Disease Treatments Market Status and Outlook
1.2 Global Parkinson's Disease Treatments Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Parkinson's Disease Treatments Market Size by Region (2018-2029)
1.4 Global Parkinson's Disease Treatments Historic Market Size by Region (2018-2023)
1.5 Global Parkinson's Disease Treatments Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Parkinson's Disease Treatments Market Size (2018-2029)
1.6.1 North America Parkinson's Disease Treatments Market Size (2018-2029)
1.6.2 Europe Parkinson's Disease Treatments Market Size (2018-2029)
1.6.3 Asia-Pacific Parkinson's Disease Treatments Market Size (2018-2029)
1.6.4 Latin America Parkinson's Disease Treatments Market Size (2018-2029)
1.6.5 Middle East & Africa Parkinson's Disease Treatments Market Size (2018-2029)
2 Parkinson's Disease Treatments Market by Type
2.1 Introduction
2.1.1 Dopamine Agonists
2.1.2 Levodopa
2.1.3 Glutamate Antagonist
2.1.4 Apomorphine
2.1.5 COMT Inhibitors Anticholinergics
2.1.6 MAO-B Inhibitors
2.1.7 Other Drugs
2.2 Global Parkinson's Disease Treatments Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Parkinson's Disease Treatments Historic Market Size by Type (2018-2023)
2.2.2 Global Parkinson's Disease Treatments Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Parkinson's Disease Treatments Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Parkinson's Disease Treatments Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Parkinson's Disease Treatments Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Parkinson's Disease Treatments Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Parkinson's Disease Treatments Revenue Breakdown by Type (2018-2029)
3 Parkinson's Disease Treatments Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Healthcare Institutes
3.1.3 Others
3.2 Global Parkinson's Disease Treatments Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Parkinson's Disease Treatments Historic Market Size by Application (2018-2023)
3.2.2 Global Parkinson's Disease Treatments Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Parkinson's Disease Treatments Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Parkinson's Disease Treatments Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Parkinson's Disease Treatments Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Parkinson's Disease Treatments Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Parkinson's Disease Treatments Revenue Breakdown by Application (2018-2029)
4 Parkinson's Disease Treatments Competition Analysis by Players
4.1 Global Parkinson's Disease Treatments Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parkinson's Disease Treatments as of 2022)
4.3 Date of Key Players Enter into Parkinson's Disease Treatments Market
4.4 Global Top Players Parkinson's Disease Treatments Headquarters and Area Served
4.5 Key Players Parkinson's Disease Treatments Product Solution and Service
4.6 Competitive Status
4.6.1 Parkinson's Disease Treatments Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GSK
5.1.1 GSK Profile
5.1.2 GSK Main Business
5.1.3 GSK Parkinson's Disease Treatments Products, Services and Solutions
5.1.4 GSK Parkinson's Disease Treatments Revenue (US$ Million) & (2018-2023)
5.1.5 GSK Recent Developments
5.2 Merck
5.2.1 Merck Profile
5.2.2 Merck Main Business
5.2.3 Merck Parkinson's Disease Treatments Products, Services and Solutions
5.2.4 Merck Parkinson's Disease Treatments Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Recent Developments
5.3 Novartis
5.3.1 Novartis Profile
5.3.2 Novartis Main Business
5.3.3 Novartis Parkinson's Disease Treatments Products, Services and Solutions
5.3.4 Novartis Parkinson's Disease Treatments Revenue (US$ Million) & (2018-2023)
5.3.5 Teva Recent Developments
5.4 Teva
5.4.1 Teva Profile
5.4.2 Teva Main Business
5.4.3 Teva Parkinson's Disease Treatments Products, Services and Solutions
5.4.4 Teva Parkinson's Disease Treatments Revenue (US$ Million) & (2018-2023)
5.4.5 Teva Recent Developments
5.5 Boehringer Ingelheim
5.5.1 Boehringer Ingelheim Profile
5.5.2 Boehringer Ingelheim Main Business
5.5.3 Boehringer Ingelheim Parkinson's Disease Treatments Products, Services and Solutions
5.5.4 Boehringer Ingelheim Parkinson's Disease Treatments Revenue (US$ Million) & (2018-2023)
5.5.5 Boehringer Ingelheim Recent Developments
5.6 Impax
5.6.1 Impax Profile
5.6.2 Impax Main Business
5.6.3 Impax Parkinson's Disease Treatments Products, Services and Solutions
5.6.4 Impax Parkinson's Disease Treatments Revenue (US$ Million) & (2018-2023)
5.6.5 Impax Recent Developments
5.7 Abbvie
5.7.1 Abbvie Profile
5.7.2 Abbvie Main Business
5.7.3 Abbvie Parkinson's Disease Treatments Products, Services and Solutions
5.7.4 Abbvie Parkinson's Disease Treatments Revenue (US$ Million) & (2018-2023)
5.7.5 Abbvie Recent Developments
5.8 Bausch Health
5.8.1 Bausch Health Profile
5.8.2 Bausch Health Main Business
5.8.3 Bausch Health Parkinson's Disease Treatments Products, Services and Solutions
5.8.4 Bausch Health Parkinson's Disease Treatments Revenue (US$ Million) & (2018-2023)
5.8.5 Bausch Health Recent Developments
5.9 Lundbeck
5.9.1 Lundbeck Profile
5.9.2 Lundbeck Main Business
5.9.3 Lundbeck Parkinson's Disease Treatments Products, Services and Solutions
5.9.4 Lundbeck Parkinson's Disease Treatments Revenue (US$ Million) & (2018-2023)
5.9.5 Lundbeck Recent Developments
5.10 Sun Pharma
5.10.1 Sun Pharma Profile
5.10.2 Sun Pharma Main Business
5.10.3 Sun Pharma Parkinson's Disease Treatments Products, Services and Solutions
5.10.4 Sun Pharma Parkinson's Disease Treatments Revenue (US$ Million) & (2018-2023)
5.10.5 Sun Pharma Recent Developments
5.11 Wockhardt
5.11.1 Wockhardt Profile
5.11.2 Wockhardt Main Business
5.11.3 Wockhardt Parkinson's Disease Treatments Products, Services and Solutions
5.11.4 Wockhardt Parkinson's Disease Treatments Revenue (US$ Million) & (2018-2023)
5.11.5 Wockhardt Recent Developments
5.12 Acadia
5.12.1 Acadia Profile
5.12.2 Acadia Main Business
5.12.3 Acadia Parkinson's Disease Treatments Products, Services and Solutions
5.12.4 Acadia Parkinson's Disease Treatments Revenue (US$ Million) & (2018-2023)
5.12.5 Acadia Recent Developments
5.13 UCB
5.13.1 UCB Profile
5.13.2 UCB Main Business
5.13.3 UCB Parkinson's Disease Treatments Products, Services and Solutions
5.13.4 UCB Parkinson's Disease Treatments Revenue (US$ Million) & (2018-2023)
5.13.5 UCB Recent Developments
6 North America
6.1 North America Parkinson's Disease Treatments Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Parkinson's Disease Treatments Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Parkinson's Disease Treatments Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Parkinson's Disease Treatments Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Parkinson's Disease Treatments Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Parkinson's Disease Treatments Market Dynamics
11.1 Parkinson's Disease Treatments Industry Trends
11.2 Parkinson's Disease Treatments Market Drivers
11.3 Parkinson's Disease Treatments Market Challenges
11.4 Parkinson's Disease Treatments Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
